Press Release

Blue Charm Launches New Initiative for Canadians Living with Multiple Sclerosis

March 1, 2023
Return to all articles

Blue Charm is excited to announce the launch of their latest offering, Blue Charm for MS, in support of people living with multiple sclerosis. The 12-week program offers participants $120 toward health expenses as they engage in weekly learning modules and patient experience surveys.

Cameron Sehl, Chief Commercial Officer of Blue Charm Adherence, stated, "We're proud to sponsor this program, which is the first-of-its-kind in Canada for anyone living with MS. Blue Charm has worked closely with patient advisory boards and MS clinic leaders to design a comprehensive program that helps patients manage their health, stay engaged with the latest research, and earn funding toward health services, including mental health counselling and physiotherapy."

The program is open to any person living with multiple sclerosis who has a current prescription for an MS DMT, regardless of manufacturer or pharmacy provider. Participants must be over 18 years old and reside in Canada, excluding Quebec. Eligible individuals can join the program by visiting www.bluecharm.io/multiplesclerosis or by downloading the free Blue Charm app for Apple or Android devices.

Healthcare providers interested in sharing this program with their patients can contact Blue Charm for referral materials.

Contact Information:

Greg Patey
Chief Executive Officer
Blue Charm Adherence
Email: g.patey@bluecharm.io

Cameron Sehl
Chief Commercial Officer
Blue Charm Adherence
Email: c.sehl@bluecharm.io

‍

Articles you might like

Insights

Closing the Gap: Bridging Patient Perception and Reality in Asthma Management

Highlighting a significant gap between patient perception and reality, this article reveals the importance of patient education and access to resources for proper disease management, including medication, symptom awareness, and trigger avoidance.
Insights

Empowering Patients: The Crucial Role of Education in Respiratory Disease Management

Respiratory Therapist with seven years of experience highlights the importance of patient education in managing respiratory diseases. This post reveals that a significant portion of COPD and Asthma patients receive an insufficient amount of education on medication use and disease management.
Insights

Five Insights from Blue Charm’s Respiratory Program in Partnership with the Canadian Lung Association

At Blue Charm, we hear directly from patients about the challenges they face, things they need, and impact of their medications. In today’s article we’re sharing a few insights from our asthma and COPD patients.